Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs

We examined whether multidrug resistant (MDR) canine lymphoma increases gene expression for platelet-derived growth factor receptor α (PDGFRα), vascular endothelial growth factor receptor 2 (VEGFR2), and c-KIT, and whether toceranib phosphate (TOC) has potential as a treatment for MDR canine lymphom...

Descripción completa

Detalles Bibliográficos
Autores principales: YAMAZAKI, Hiroki, MIURA, Naoki, LAI, Yu-Chang, TAKAHASHI, Masashi, GOTO-KOSHINO, Yuko, YASUYUKI, Momoi, NAKAICHI, Munekazu, TSUJIMOTO, Hajime, SETOGUCHI, Asuka, ENDO, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2017
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559368/
https://www.ncbi.nlm.nih.gov/pubmed/28592719
http://dx.doi.org/10.1292/jvms.16-0457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559368/
https://www.ncbi.nlm.nih.gov/pubmed/28592719
http://dx.doi.org/10.1292/jvms.16-0457

Ejemplares similares